Abstract 6637: Inhibition of FGFR signaling by lenvatinib activates tumor interferon gamma signaling pathway and potentiates antitumor activity of anti-PD-1 antibody
Year: 2020
Type: conference-abstract
Source: Cancer Research
Authors: Yusuke Adachi, Hiroshi Kamiyama, Kenji Ichikawa, Yoichi Ozawa, Sayo Fukushima, Satoshi Goda, Shogo Yamaguchi, Masahiro Matsuki, Saori Watanabe Miyano, Akira Yokoi, Yu Kato, Yasuhiro Funahashi
Institution: Eisai (Japan)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: lenvatinib, FGFR signaling, interferon-gamma signaling, anti-PD-1 therapy, anti-PD-1, renal cell carcinoma, axitinib, VEGF inhibition, PD-L1 expression, STAT1 phosphorylation, SOCS1, JAK/STAT signaling, tumor microenvironment, combination immunotherapy, immune checkpoint inhibitors, tyrosine kinase inhibitors, endometrial cancer
Open Access status: closed
OpenAlex ID: W3083321144
